1. Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway
    Liang-Tsai Yeh et al, 2022, International Journal of Molecular Sciences CrossRef
  2. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells
    Laura Valdez et al, 2022, Oncotarget CrossRef
  3. Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
    Sze-Kwan Lam et al, 2022, Frontiers in Pharmacology CrossRef
  4. A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living Cells
    Kenji Schorpp et al, 2016, SLAS Discovery CrossRef
  5. Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
    N. G. R. Dayan Elshan et al, 2019, Medicinal Research Reviews CrossRef
  6. Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma
    Gireesh B. Reddy et al, 2020, Molecular Cancer Therapeutics CrossRef
  7. Niclosamide: A career builder
    David Needham, 2024, Journal of Controlled Release CrossRef
  8. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
    Hyeon Woong Kang et al, 2023, Cancer Biology & Therapy CrossRef
  9. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing
    Rawikant Kamolphiwong et al, 2023, Gene CrossRef
  10. Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
    Xiaoling Huang et al, 2023, Genetics and Molecular Biology CrossRef
  11. Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway
    XIAOLONG YU et al, 2015, Oncology Reports CrossRef
  12. Wnt Signaling in Osteosarcoma
    Amit Singla et al, 2020, Current Advances in the Science of Osteosarcoma CrossRef
  13. Effect of the Wnt/β-catenin pathway inhibitors on cell proliferation and migration of HEC-1A endometrial adenocarcinoma: experimental cell culture model
    Yaşam ÇİRÇİRCİ et al, 2021, The European Research Journal CrossRef
  14. Niclosamide nanocrystal for enhanced in-vivo efficacy against gastrointestinal stromal tumor via regulating EGFR/STAT-3/DR-4 axis
    NP Syamprasad et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  15. Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer
    Yufen Yan et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  16. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation
    Lu Huang et al, 2017, Antiviral Research CrossRef
  17. Development of clinically effective formulations for anticancer applications: why it is so difficult?
    David Needham, 2020, Biomaterials for Cancer Therapeutics CrossRef
  18. Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
    Benxu Cheng et al, 2017, PLOS ONE CrossRef